Inaugural Allergan Horizon Grant recipients announced
Allergan announced the recipients of the first Allergan Horizon Grant Program. The company will contribute $1 million over 2 years to academic medical institutions to support fellows seeking to develop careers in academic medicine. The awards will fund fellowship programs that conduct clinical research in the diagnosis or pharmacological treatment of glaucoma, corneal, and retinal diseases.
Allergan announced the recipients of the first Allergan Horizon Grant Program. The company will contribute $1 million over 2 years to academic medical institutions to support fellows seeking to develop careers in academic medicine. The awards will fund fellowship programs that conduct clinical research in the diagnosis or pharmacological treatment of glaucoma, corneal, and retinal diseases.
Ten grants were awarded to 13 ophthalmology programs. Three programs will share the $40,000 between two therapeutic areas.
The recipients include: Cornea
Anthony Aldave, MD, Jules Stein Eye Institute, University of California, Los Angeles
Roy S. Chuck, MD, Wilmer Eye Institute, Johns Hopkins University, Baltimore
Terry Kim, MD, Duke University Eye Center
Stephen Pflugfelder, MD, Cullen Eye Institute, Department of Ophthalmology, Baylor College of Medicine
Glaucoma
Rand Allingham, MD, Duke University Medical Center
James D. Brandt, MD, University of California, Davis
Joseph Caprioli, MD, Jules Stein Eye Institute, University of California, Los Angeles
Robert Ritch, MD, New York Eye & Ear Infirmary
Robert Weinreb, MD, University of California, San Diego
Retina
Neil Bressler, MD, Wilmer Eye Institute
Stanley Chang, MD, Columbia University
Carmen Puliafito, MD, Bascom Palmer Eye Institute
Paul Sternberg Jr., MD, Vanderbilt Eye Institute
For more information, visit Allergan at Booth 2831.